Perfil del autor: García-Domínguez, Daniel J.
Datos institucionales
Nombre | García-Domínguez, Daniel J. |
Departamento | Bioquímica Médica y Biología Molecular e Inmunología |
Área de conocimiento | Bioquímica y Biología Molecular |
Categoría profesional | Plan Propio-Acceso |
Correo electrónico | Solicitar |
![]() ![]() ![]() ![]() ![]() ![]() |
Estadísticas
-
Nº publicaciones
13
-
Nº visitas
991
-
Nº descargas
538
Publicaciones |
---|
Artículo
![]() Cancer nano-immunotherapy: the novel and promising weapon to fight cancer
(Mdpi Ag, 2024)
Cancer is a complex disease that, despite advances in treatment and the greater understanding of the tumor biology until ... |
Artículo
![]() Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
(Mdpi Ag, 2023)
Breast cancer (BC) continues to be the most diagnosed tumor in women and a very heterogeneous disease both inter- and ... |
Artículo
![]() Obesity and Risk for Lymphoma: Possible Role of Leptin
(MDPI, 2022)
Obesity, which is considered a pandemic due to its high prevalence, is a risk factor for many types of cancers, including ... |
Artículo
![]() Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies
(MDPI, 2022)
Ewing Sarcoma (EWS) is an aggressive bone and soft tissue tumor that mainly affects children, adolescents, and young adults. ... |
Artículo
![]() ![]() Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics
(MDPI, 2022)
Lymphoma is a neoplasm arising from B or T lymphocytes or natural killer cells characterized by clonal lymphoproliferation. ... |
Artículo
![]() ![]() Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1
(Nature Publishing Group, 2022)
Ewing sarcoma (EWS) is an aggressive bone and soft tissue tumor with high susceptibility to metastasize. The underlying ... |
Artículo
![]() The bitter side of epigenetics: variability and resistance to chemotherapy
(Future Medicine, 2021)
One of the major obstacles to the development of effective new cancer treatments and the main factor for the increasing ... |
Artículo
![]() Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma
(Springer Nature, 2021)
Ewing sarcoma (EWS) is an aggressive bone and soft tissue tumor of children and young adults in which the principal driver ... |
Artículo
![]() An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogénesis
(Public Library of Science, 2020)
The presence of the chimeric EWSR1-FLI1 oncoprotein is the main and initiating event defining Ewing sarcoma (ES). The ... |
Artículo
![]() Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
(Frontiers Media S.A., 2020)
Chemotherapy is one of the most established and effective treatments for almost all types of cancer. However, the elevated ... |
Tesis Doctoral
![]() Estudio de los coactivadores transcripcionales TAZ y YAP1 en el sarcoma de Ewing: Implicación en la progresión tumoral e interacción funcional con la proteína de fusión EWS-FLI1
(2019)
La presente tesis doctoral aborda, por primera vez, el papel funcional de los dos efectores finales de la vía Hippo, TAZ ... |
Artículo
![]() Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients
(Impact Journals, 2017)
Wilms tumour (WT) is the most common renal tumour in children. Most WT patients respond to chemotherapy, but subsets of ... |
Artículo
![]() HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients
(Impact Journals, 2017)
Wilms tumor (WT) is an embryonal malignant neoplasm of the kidney that accounts for 6–7% of all childhood cancers. WT seems ... |